The Clinical Trial Landscape in PSC: Current and New Opportunities for Patients

Third Webinar in Our Post-Conference Webinar Series
The Clinical Trial Landscape in PSC: Current and New Opportunities for Patients

Experts discussed PSC studies and clinical trials.
Presenters:
Brigham and Women’s Hospital: Josh Korzenik, MD
Chemomab Therapeutics: Jack Lawler, VP Global Clinical Development Operations
CymaBay Therapeutics: Sujal Shah, President & CEO
Escient Pharmaceuticals: Represented by Gideon Hirschfield, B Chir, MRCP, PhD, University of Toronto
Gilead Sciences: Lisa Boyette, MD, PhD
HighTide Therapeutics: Leigh MacConell, PhD, Chief Development Officer Mayo Clinic: John Eaton, MD
Mirum Pharmaceuticals: Elaine Chien, MD, Vice President, Clinical Development and Medical Safety
Pliant Therapeutics: Rich Pencek, PhD, Senior Director, Clinical Development

"I applaud everyone who's here tonight. It's not about competition. It's about finding ways to work together," said Sujal Shah, President & CEO, CymaBay Therapeutics.